Bernardo Nadal-Ginard is an internationally recognized cardiologist, biomedical researcher, and educator. His pioneering work in molecular cardiology and regenerative medicine has shaped the scientific understanding of cardiac repair and stem cell biology. Over the course of a career that has spanned more than five decades, Bernardo Nadal-Ginard has held leading academic and research positions at some of the world’s most prestigious institutions, including Harvard Medical School, Tokyo Women’s Medical University, and the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid.

In the late 1990s and early 2000s, Dr. Nadal-Ginard became a visiting professor at the New York Medical College. He later served as a senior investigator at the school’s cardiovascular research institute. His expertise in molecular cardiology and regenerative medicine led to the founding of Arta Research Consulting LLP in 1997, where he served as principal, providing guidance on biomedical innovation and translational research strategy.

Today, Dr. Nadal-Ginard is the CEO of StemCell Operating Co. He serves as the company’s principal investigator, overseeing research design, execution, data analysis, and compliance management.